Literature DB >> 15340111

Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.

Aparajita Dey1, Roger S Williams, David M Pollock, David W Stepp, John W Newman, Bruce D Hammock, John D Imig.   

Abstract

OBJECTIVE: To determine cytochrome P450 (CYP450) and cyclooxygenase (COX) expression and metabolite regulation and renal damage in the early stages of obesity-related hypertension and diabetes. RESEARCH METHODS AND PROCEDURES: Obese and lean Zucker rats at 10 to 12 weeks of age were studied. Blood pressure was measured in the conscious state using radiotelemetry. Blood glucose levels and body weight were measured periodically. Protein expression of CYP450 and COX enzymes in the kidney cortex, renal microvessels, and glomeruli was studied. The levels of CYP450 and COX metabolites in urine were measured, and urinary albumin excretion, an indicator of kidney damage, was measured.
RESULTS: Body weight and blood glucose averaged 432 +/- 20 grams and 105 +/- 5 mg/dl, respectively, in obese Zucker rats as compared with 320 +/- 8 grams and 91 +/- 5 mg/dl, respectively, in age-matched 10- to 12-week-old lean Zucker rats. Renal microvascular CYP4A and COX-2 protein levels were increased 2.3- and 17.0-fold, respectively, in obese Zucker rats. The protein expression of CYP2C11 and CYP2C23 was decreased 2.0-fold in renal microvessels isolated from obese Zucker rats when compared with lean Zucker rats. The urinary excretion rate of thromboxane B(2) was increased significantly in obese Zucker as compared with lean Zucker rats (22.0 +/- 1.8 vs. 13.4 +/- 1.0 ng/d). Urinary albumin excretion, an index of kidney damage, was increased in the obese Zucker rat at this early age. DISCUSSION: These results suggest that increased CYP4A and COX-2 protein levels and decreased CYP2C11 and CYP2C23 protein levels occur in association with microalbuminuria during the onset of obesity-related hypertension and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340111     DOI: 10.1038/oby.2004.162

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  16 in total

1.  Cytochrome P450 (CYP) epoxygenases as potential targets in the management of impaired diabetic wound healing.

Authors:  Huichen Zhao; Jicui Chen; Jiachao Chai; Yuchao Zhang; Cong Yu; Zhe Pan; Peng Gao; Chen Zong; Qingbo Guan; Yuqin Fu; Yuantao Liu
Journal:  Lab Invest       Date:  2017-03-20       Impact factor: 5.662

2.  Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.

Authors:  Abdul Hye Khan; John D Imig
Journal:  Am J Hypertens       Date:  2011-03-17       Impact factor: 2.689

3.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

Review 4.  Glomerular endothelial cell injury and cross talk in diabetic kidney disease.

Authors:  Jia Fu; Kyung Lee; Peter Y Chuang; Zhihong Liu; John Cijiang He
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-19

Review 5.  The transcriptional regulation of the human CYP2C genes.

Authors:  Yuping Chen; Joyce A Goldstein
Journal:  Curr Drug Metab       Date:  2009-07-15       Impact factor: 3.731

6.  Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.

Authors:  Pengcheng Luo; Yiqiang Zhou; Hsin-Hsin Chang; Jie Zhang; Tsugio Seki; Cong-Yi Wang; Edward W Inscho; Mong-Heng Wang
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07

7.  Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.

Authors:  David A Osmond; Shali Zhang; Jennifer S Pollock; Tatsuo Yamamoto; Carmen De Miguel; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-29

8.  High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats.

Authors:  Xiaodong Sun; Yerong Yu; Lina Han
Journal:  Int Urol Nephrol       Date:  2013-04-06       Impact factor: 2.370

Review 9.  Eicosanoids and renal damage in cardiometabolic syndrome.

Authors:  John D Imig
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-02       Impact factor: 4.481

10.  Constitutive activation of AMPK α1 in vascular endothelium promotes high-fat diet-induced fatty liver injury: role of COX-2 induction.

Authors:  Yan Liang; Bosheng Huang; Erfei Song; Bo Bai; Yu Wang
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.